Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts

Radiology

Volumn 258, Issue 1, 2011, Pages 106-118

  Rhodes, Deborah J ^a   Hruska, Carrie B ^a   Phillips, Stephen W ^a,b   Whaley, Dana H ^a   O'Connor, Michael K ^a  

^a MAYO CLINIC   (United States)

^b Breast Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM DERIVATIVE; CADMIUM ZINC TELLURIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TELLURIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; EXCISION; FEMALE; FOLLOW UP; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; SCINTILLATION CAMERA; SECOND CANCER; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GAMMA CAMERAS; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 78650611558     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100625     Document Type: Article

References (53)

1. US Preventive Services Task Force. Screening for breast cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;551(10):716-726, W-236.
2. [Published correction appears in Ann Intern Med 2010;552(3):199-200.]
3. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;52(5):793-806.
4. D'Orsi CI, Bassett L W, Berg WA, et al. Breast Imaging Reporting and Data System, BI-RADS: mammography. 4th ed. Reston, Va: American College of Radiology, 2003.
5. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992;54(10):781-785.
6. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;56(19):1432-1440.
7. Lehman CD, White E, Peacock S, Drucker MJ, Urban N. Effect of age and breast density on screening mammograms with falsepositive findings. AJR Am J Roentgenol 1999;573(6):1651-1655.
8. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;538(3):168-175.
9. Leconte I, Feger C, Galant C, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 2003;580(6):1675-1679.
10. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27, 825 patient evaluations. Radiology 2002;525(1):165-175.
11. Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 2008;546(2):376-383.
12. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of intervaland screen-detected cancers. J Natl Cancer Inst 2000;52(13):1081-1087.
13. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;556(3):227-236.
14. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;599(18):2151-2163.
15. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;593(10):1245-1256.
16. Berg WA, Blume JD, Adams AM, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 2010;554(1):79-87.
17. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75-89.
18. Khalkhali I, Baum JK, Villanueva-Meyer J, et al. (99m) Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology 2002;522(1):149-155.
19. Hruska CB, O'Connor MK, Collins DA. Comparison of small field of view gamma camera systems for scintimammography. Nucl Med Commun 2005;56(5):441-445.
20. Hruska CB, O'Connor MK. Effect of collimator selection on tumor detection for dedicated nuclear breast imaging systems. IEEE Trans Nucl Sci 2006;53(5):2680-2689.
21. Scopinaro F, Pani R, De Vincentis G, Soluri A, Pellegrini R, Porfiri LM. High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera. Eur J Nucl Med 1999;56(10):1279-1288.
22. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. Highresolution scintimammography: a pilot study. J Nucl Med 2002;53(7):909-915.
23. O'Connor MK, Phillips SW, Rhodes DJ, Collins DA. Reliable detection of small breast tumors with Tc-99m sestamibi and a dedicated small field of view gamma camera [abstr]. J Nucl Med 2004;55(suppl):357P.
24. Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc 2005;50(1):24-30.
25. O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J 2007;53(1):3-11.
26. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol 2008;591(6):1805-1815.
27. Zhou M, Johnson N, Gruner S, et al. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg 2009;597(2):159-163.
28. Spanu A, Chessa F, Meloni GB, et al. The role of planar scintimammography with highresolution dedicated breast camera in the diagnosis of primary breast cancer. Clin Nucl Med 2008;53(11):739-742.
29. Spanu A, Chessa F, Battista Meloni G, et al. Scintimammography with high resolution dedicated breast camera and mammography in multifocal, multicentric and bilateral breast cancer detection: a comparative study. Q J Nucl Med Mol Imaging 2009;53(2):133-143.
30. Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med 2004;55(4):553-558.
31. Brem RF, Rapelyea JA, Zisman G, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 2005;537(1):274-280.
32. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006;52(4):309-323.
33. Kerlikowske K, Ichikawa L, Miglioretti DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007;59(5):386-395.
34. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 1996;567(5):1261-1265.
35. Mueller B, O'Connor MK, Blevis I, et al. Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med 2003;54(4):602-609.
36. Moskowitz CS, Pepe MS. Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs. Clin Trials 2006;5(3):272-279.
37. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;57(8):857-872.
38. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;50(1):37-46.
39. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;53(1):159-174.
40. Tavassoli FA, Devilee P, World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon, France: International Agency for Research on Cancer, 2003.
41. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;592(11):1317-1325.
42. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;553(17):1773-1783.
43. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;542(3):698-715.
44. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004;592(22):2735-2742.
45. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;533(3):830-849.
46. Echevarria JJ, Martín M, Saiz A, et al. Overall breast density in MR mammography: diagnostic and therapeutic implications in breast cancer. J Comput Assist Tomogr 2006;50(1):140-147.
47. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004;583(4):1149-1157.
48. Weinmann AL, Hruska CB, O'Connor MK. Design of optimal collimation for dedicated molecular breast imaging systems. Med Phys 2009;56(3):845-856.
49. O'Connor MK, Tourassi G, Orton CG. Point/counterpoint: molecular breast imaging will soon replace x-ray mammography as the imaging modality of choice for women at high risk with dense breasts. Med Phys 2009;56(5):1463-1466.
50. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 1989;53(1):181-187.
51. Fisher ER, Costantino J, Fisher B, Redmond C. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4): discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators. Cancer 1993;51(6 suppl):2141-2150.
52. Rosen PP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 1993;51(11):2090-2100.
53. Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003;58(10):2133- 2143.